# Insulin Regulation and Severity of Severe Acute Respiratory Syndrome COVID-19 Infection

> **NCT05897528** · — · COMPLETED · sponsor: **Arrowhead Regional Medical Center** · enrollment: 589 (actual)

## Conditions studied

- COVID-19
- Diabetes Mellitus
- COVID-19 Pneumonia
- COVID-19 Respiratory Infection

## Interventions

- **OTHER:** No Intervention

## Key facts

- **NCT ID:** NCT05897528
- **Lead sponsor:** Arrowhead Regional Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-14
- **Primary completion:** 2022-12-30
- **Final completion:** 2022-12-30
- **Target enrollment:** 589 (ACTUAL)
- **Last updated:** 2023-06-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05897528

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05897528, "Insulin Regulation and Severity of Severe Acute Respiratory Syndrome COVID-19 Infection". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05897528. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*